-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OhR9By0Vaibuk2O0I0HlCbXeujMAGC1IBaHKN7Je36ZyBTuf/pPIWspCjXojXSZ7 oxl2zjeZ8GopVlNW2KkxgA== 0000929638-00-000033.txt : 20000215 0000929638-00-000033.hdr.sgml : 20000215 ACCESSION NUMBER: 0000929638-00-000033 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CARDIMA INC CENTRAL INDEX KEY: 0001022570 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 943177883 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-52701 FILM NUMBER: 543695 BUSINESS ADDRESS: STREET 1: 47266 BENICIA STREET CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 5103540300 MAIL ADDRESS: STREET 1: 47266 BENICIA ST CITY: FREMONT STATE: CA ZIP: 94538 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TARGET THERAPEUTICS INC CENTRAL INDEX KEY: 0000882238 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 953962471 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 47201 LAKEWIEW BLVD CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 5104407700 MAIL ADDRESS: STREET 1: 47201 LAKEVIEW BLVD CITY: FREMONT STATE: CA ZIP: 94538 SC 13G/A 1 SCHEDULE G, AMENDMENT NO. 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13D-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(B), (C), AND (D) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(B) (AMENDMENT NO. 1)(1) CARDIMA, INC. ------------------------------------------ (Name of Issuer) Common Stock, $0.001 par value per share ------------------------------------------ (Title or Class of Securities) 00014147M1 ------------------------------------------ (CUSIP Number) December 31, 1999 ------------------------------------------ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - -------------- 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 00014147M1 13G Page 2 of 5 Pages - ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Target Therapeutics, Inc. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ] Not applicable. (B) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION The State of Delaware - ------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF Not applicable. SHARES ------------------------------------------------------ BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH Not applicable. REPORTING ------------------------------------------------------ PERSON 7 SOLE DISPOSITIVE POWER WITH Not applicable. ------------------------------------------------------ 8 SHARED DISPOSITIVE POWER Not applicable. - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON Not applicable. - ------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* Not applicable. [ ] - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) Not applicable. - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - ------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP NO. 00014147M1 13G Page 3 of 5 Pages ITEM 1(A). NAME OF ISSUER: Cardima, Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 47266 Benicia Street Fremont, CA 94538 ITEM 2(A). NAME OF PERSON FILING: Target Therapeutics, Inc. ITEM 2(B). ADDRESS OF PRINICIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 47201 Lakeview Boulevard Fremont, CA 94538 ITEM 2(C). CITIZENSHIP: The State of Delaware ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock, $0.001 par value per share ITEM 2(E). CUSIP NUMBER: 00014147M1 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A: Not applicable. ITEM 4. OWNERSHIP: (a) Amount beneficially owned: Not applicable. (b) Percent of class: Not applicable. (c) Number of shares as to which such person has: (i) Sole Power to vote or to direct the vote: Not applicable. (ii) Shared power to vote or to direct the vote: Not applicable. (iii) Sole power to dispose or to direct the disposition of: Not applicable. (iv) Shared power to dispose or to direct the disposition of: Not applicable. CUSIP NO. 00014147M1 13G Page 4 of 5 Pages ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [X] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10. CERTIFICATIONS: Not applicable. CUSIP NO. 00014147M1 13G Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2000 ------------------------------- (Date) TARGET THERAPEUTICS, INC. By: /s/ Lawrence J. Knopf --------------------------- Name: Lawrence J. Knopf Title: Assistant Secretary -----END PRIVACY-ENHANCED MESSAGE-----